Source link : https://newshealth.biz/health-news/tafasitamab-combo-boosts-r-chop-in-frontline-dlbcl/
Tafasitamab and lenalidomide are likely to be approved with R-CHOP for frontline DLBCL, but with bispecific antibodies on the horizon, the role of the combination is uncertain. Medscape Medical News Source link : https://www.medscape.com/viewarticle/tafasitamab-combo-boosts-r-chop-frontline-dlbcl-2026a1000i14?src=rss Author : Publish date : 2026-05-30 12:05:00 Copyright for syndicated content belongs to the linked Source.
The post Tafasitamab Combo Boosts R-CHOP in Frontline DLBCL first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-30 12:05:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8